Dr. Lynch on the Goals of Bristol-Myers Squibb

Video

Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses goals at Bristol-Myers Squibb.

Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses the goals of Bristol-Myers Squibb.

Lynch believes that physicians are motivated by 2 things—the desire to help patients and the sense of mission of the hospital, doctors, and nurses. These caregivers are working together for a common cause. Bristol-Myers Squibb embodies that same sense of a common cause, explains Lynch. The common cause centers around the idea of scientists, regulatory agencies, and clinical trial developers working together to create better medicine, states Lynch.

Over the next several years, Lynch says that his goals are to improve the ability of these medicines to make a difference in improving the cure rate for cancers and help people live longer, he says.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,